1mwp: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Amyloid precursor protein (APP) plays a central role in Alzheimer disease., A proteolytic-breakdown product of APP, called beta-amyloid, is a major, component of the diffuse and fibrillar deposits found in Alzheimer, diseased brains. The normal physiological role of APP remains largely, unknown despite much work. A knowledge of its function will not only, provide insights into the genesis of the disease but may also prove vital, in the development of an effective therapy. Here we describe the 1.8 A, resolution crystal structure of the N-terminal, heparin-binding domain of, APP (residues 28-123), which is responsible, among other things, for, stimulation of neurite outgrowth. The structure reveals a highly charged, basic surface that may interact with glycosaminoglycans in the brain and, an abutting hydrophobic surface that is proposed to play an important, functional role such as dimerization or ligand binding. Structural, similarities with cysteine-rich growth factors, taken together with its, known growth-promoting properties, suggests the APP N-terminal domain, could function as a growth factor in vivo.
Amyloid precursor protein (APP) plays a central role in Alzheimer disease. A proteolytic-breakdown product of APP, called beta-amyloid, is a major component of the diffuse and fibrillar deposits found in Alzheimer diseased brains. The normal physiological role of APP remains largely unknown despite much work. A knowledge of its function will not only provide insights into the genesis of the disease but may also prove vital in the development of an effective therapy. Here we describe the 1.8 A resolution crystal structure of the N-terminal, heparin-binding domain of APP (residues 28-123), which is responsible, among other things, for stimulation of neurite outgrowth. The structure reveals a highly charged basic surface that may interact with glycosaminoglycans in the brain and an abutting hydrophobic surface that is proposed to play an important functional role such as dimerization or ligand binding. Structural similarities with cysteine-rich growth factors, taken together with its known growth-promoting properties, suggests the APP N-terminal domain could function as a growth factor in vivo.


==Disease==
==Disease==
Line 19: Line 19:
[[Category: Beyreuther, K.]]
[[Category: Beyreuther, K.]]
[[Category: Cappai, R.]]
[[Category: Cappai, R.]]
[[Category: Feil, S.C.]]
[[Category: Feil, S C.]]
[[Category: Galatis, D.]]
[[Category: Galatis, D.]]
[[Category: Henry, A.]]
[[Category: Henry, A.]]
[[Category: Hesse, L.]]
[[Category: Hesse, L.]]
[[Category: Masters, C.L.]]
[[Category: Masters, C L.]]
[[Category: McKinstry, W.J.]]
[[Category: McKinstry, W J.]]
[[Category: Multhaup, G.]]
[[Category: Multhaup, G.]]
[[Category: Parker, M.W.]]
[[Category: Parker, M W.]]
[[Category: Rossjohn, J.]]
[[Category: Rossjohn, J.]]
[[Category: heparin binding]]
[[Category: heparin binding]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:26:10 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:59:54 2008''